Glenmede Trust Co. NA trimmed its position in shares of Arcosa, Inc. (NYSE:ACA – Free Report) by 1.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 203,874 shares of the company’s stock after selling 2,760 shares during the quarter. Glenmede Trust Co. NA’s holdings in Arcosa were worth $19,319,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in ACA. Stonegate Investment Group LLC boosted its position in Arcosa by 3.6% during the 3rd quarter. Stonegate Investment Group LLC now owns 3,095 shares of the company’s stock worth $293,000 after buying an additional 108 shares during the period. Xponance Inc. lifted its holdings in shares of Arcosa by 4.4% during the second quarter. Xponance Inc. now owns 3,073 shares of the company’s stock worth $256,000 after purchasing an additional 130 shares during the period. Sei Investments Co. grew its stake in shares of Arcosa by 1.1% in the second quarter. Sei Investments Co. now owns 13,495 shares of the company’s stock worth $1,126,000 after purchasing an additional 146 shares during the last quarter. Arizona State Retirement System increased its holdings in Arcosa by 1.5% in the second quarter. Arizona State Retirement System now owns 13,595 shares of the company’s stock valued at $1,134,000 after purchasing an additional 195 shares during the period. Finally, Evergreen Capital Management LLC raised its position in Arcosa by 5.5% during the 2nd quarter. Evergreen Capital Management LLC now owns 4,444 shares of the company’s stock worth $371,000 after purchasing an additional 233 shares during the last quarter. Institutional investors and hedge funds own 90.66% of the company’s stock.
Insider Activity
In other news, Director Steven J. Demetriou acquired 6,000 shares of the firm’s stock in a transaction dated Thursday, September 12th. The stock was purchased at an average price of $87.70 per share, for a total transaction of $526,200.00. Following the completion of the acquisition, the director now directly owns 9,943 shares in the company, valued at $872,001.10. The trade was a 152.17 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 1.30% of the company’s stock.
Arcosa Stock Down 1.3 %
Arcosa (NYSE:ACA – Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.78 by $0.13. The firm had revenue of $640.40 million for the quarter, compared to analyst estimates of $682.52 million. Arcosa had a return on equity of 6.64% and a net margin of 5.17%. The company’s revenue was up 8.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.73 earnings per share. Equities research analysts predict that Arcosa, Inc. will post 3.38 earnings per share for the current year.
Arcosa Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, October 31st. Shareholders of record on Tuesday, October 15th were issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 0.19%. The ex-dividend date was Tuesday, October 15th. Arcosa’s payout ratio is 7.60%.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on ACA shares. Barclays assumed coverage on Arcosa in a research note on Tuesday, October 29th. They issued an “overweight” rating and a $106.00 price target for the company. Stephens upgraded Arcosa from an “equal weight” rating to an “overweight” rating and set a $96.00 target price on the stock in a report on Wednesday, August 7th. Finally, Oppenheimer raised their price target on shares of Arcosa from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Monday, August 19th.
Get Our Latest Research Report on ACA
Arcosa Profile
Arcosa, Inc, together with its subsidiaries, provides infrastructure-related products and solutions for the construction, engineered structures, and transportation markets in the United States. It operates through three segments: Construction Products, Engineered Structures, and Transportation Products.
Featured Stories
- Five stocks we like better than Arcosa
- What is the Australian Securities Exchange (ASX)
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Profitably Trade Stocks at 52-Week Highs
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding ACA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arcosa, Inc. (NYSE:ACA – Free Report).
Receive News & Ratings for Arcosa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcosa and related companies with MarketBeat.com's FREE daily email newsletter.